Vincerx Pharma, Inc. financial data

Symbol
VINC on OTC
Location
260 Sheridan Avenue, Suite 400, Palo Alto, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 220 % -2.02%
Debt-to-equity 67.5 % -15.6%
Return On Equity -309 % -2.67%
Return On Assets -184 % -10.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.23M shares -75.6%
Common Stock, Shares, Outstanding 5.23M shares -75.6%
Entity Public Float 21M USD -8.7%
Common Stock, Value, Issued 1K USD -50%
Weighted Average Number of Shares Outstanding, Basic 3.58K shares +230%
Weighted Average Number of Shares Outstanding, Diluted 3.58K shares +230%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 15.4M USD +27.4%
Operating Income (Loss) -27.3M USD +21.2%
Nonoperating Income (Expense) 4.67M USD +66.4%
Net Income (Loss) Attributable to Parent -22.6M USD +40.3%
Earnings Per Share, Basic -6 USD/shares +88.1%
Earnings Per Share, Diluted -6 USD/shares +88.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.44M USD -13.2%
Marketable Securities, Current 7.14M USD +24.8%
Cash, Cash Equivalents, and Short-term Investments 20.8M USD
Other Assets, Current 44K USD -94.2%
Assets, Current 4.69M USD -39%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 1.6M USD +37.7%
Assets 4.69M USD -57.7%
Accounts Payable, Current 2.27M USD -1.95%
Accrued Liabilities, Current 351K USD -79.7%
Liabilities, Current 2.62M USD -75.4%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 2.62M USD -77.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 170K USD +183%
Retained Earnings (Accumulated Deficit) -194M USD -13.2%
Stockholders' Equity Attributable to Parent 2.07M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.5B USD
Liabilities and Equity 4.69M USD -57.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.45M USD +42.4%
Net Cash Provided by (Used in) Financing Activities 3.86M USD +77020%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 5.23M shares -75.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -547K USD +92.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.52M USD -13%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 41M USD +8.49%
Deferred Tax Assets, Gross 41M USD +7%
Operating Lease, Liability 1.64M USD -40.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -22.5M USD +40.6%
Lessee, Operating Lease, Liability, to be Paid 3.04M USD
Property, Plant and Equipment, Gross 0 USD -100%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.37M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.32M USD
Operating Lease, Weighted Average Discount Rate, Percent 0 pure -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 90K USD -66.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 28K USD
Deferred Tax Assets, Operating Loss Carryforwards 19.4M USD +25.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 30M shares 0%
Unrecognized Tax Benefits 1.54M USD +24.4%
Operating Lease, Payments 990K USD -22.8%
Additional Paid in Capital 196M USD +14.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 3.38M USD +24.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%